|
Volumn 68, Issue 5, 2012, Pages 877-879
|
EMA's reflection on placebo does not reflect patients' interests
|
Author keywords
Clinical research; Drug regulation; Pharmacological research; Placebo; Randomized clinical trials; Three arm trials
|
Indexed keywords
NEW DRUG;
PLACEBO;
CLINICAL STUDY;
CLINICAL TRIAL (TOPIC);
DRUG DEVELOPMENT;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SAFETY;
EXPERIMENTAL MEDICINE;
FOOD AND DRUG ADMINISTRATION;
GOOD CLINICAL PRACTICE;
HEALTH CARE ORGANIZATION;
HEALTH CARE SYSTEM;
HUMAN;
MEDICAL ETHICS;
NOTE;
PATIENT SAFETY;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
CONSUMER ADVOCACY;
DRUG INDUSTRY;
EUROPEAN UNION;
GOVERNMENT AGENCIES;
HELSINKI DECLARATION;
HUMANS;
INTERNATIONAL AGENCIES;
PATIENT ADVOCACY;
PATIENT RIGHTS;
PATIENT SAFETY;
PLACEBOS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESEARCH DESIGN;
RESEARCH SUBJECTS;
WITHHOLDING TREATMENT;
|
EID: 84864290659
PISSN: 00316970
EISSN: 14321041
Source Type: Journal
DOI: 10.1007/s00228-011-1175-4 Document Type: Note |
Times cited : (9)
|
References (9)
|